Advertisement

Comment on “Impact of TNF-Α inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: 2-year follow-up data from the catholic axial spondyloarthritis cohort (CASCO)”

  • 3 Accesses

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.

References

  1. 1.

    Min HK, Lee J, Ju JH, Park SH, Kwok SK (2019) Impact of TNF-α inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: 2-year follow-up data from the Catholic axial Spondyloarthritis COhort (CASCO). Clin Rheumatol 1–7. https://doi.org/10.1007/s10067-019-04767-z

  2. 2.

    Cure E, Icli A, Uslu AU, Sakiz D, Cure MC, Baykara RA (2018) Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis: AIP associate with cIMT in AS. Clin Rheumatol 37:1273–1280

  3. 3.

    Bergström U, Jovinge S, Persson J, Jacobsson LTH, Turesson C (2018) Effects of treatment with adalimumab on blood lipid levels and atherosclerosis in patients with rheumatoid arthritis. Curr Ther Res Clin Exp 89:1–6

  4. 4.

    Pollono EN, Lopez-Olivo MA, Lopez JA, Suarez-Almazor ME (2010) A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol 29:947–955

  5. 5.

    Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA (2006) Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 33:921–923

  6. 6.

    Maneiro JR, Souto A, Gomez-Reino JJ (2017) Impact of treatment with TNF antagonists on total cholesterol in patients with ankylosing spondylitis and psoriatic arthritis. Clin Rheumatol 36:1167–1172

  7. 7.

    Maia DG, Augusto KL, Bezerra MC, Rodrigues CEM (2017) Metabolic syndrome in patients with ankylosing spondylitis receiving anti-TNFα therapy: association with predictors of cardiovascular risk. Clin Rheumatol 36:2371–2376

  8. 8.

    Kucuk A, Uğur Uslu A, Icli A, Cure E, Arslan S, Turkmen K, Toker A, Kayrak M (2017) The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis. Z Rheumatol 76:58–63

  9. 9.

    Karimifar M, Sepehrifar MS, Moussavi H, Sepehrifar MB, Mottaghi P, Siavash M et al (2018) The effects of conventional drugs in the treatment of rheumatoid arthritis on the serum lipids. J Res Med Sci 23:105

Download references

Author information

Correspondence to Erkan Cure.

Ethics declarations

Conflict of interest

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

See related article, https://doi.org/10.1007/s10067-020-04935-6

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cure, E., Cumhur Cure, M. Comment on “Impact of TNF-Α inhibitor on lipid profile and atherogenic index of plasma in axial spondyloarthritis: 2-year follow-up data from the catholic axial spondyloarthritis cohort (CASCO)”. Clin Rheumatol (2020) doi:10.1007/s10067-019-04911-9

Download citation